Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Kinnate Biopharma Inc. (KNTE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
4 May 2023
GORDON CARL L
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
1,368,339
+1577%
1,460,932
$2.80
$4,086,234.50
BUY
4 May 2023
ORBIMED ADVISORS LLC
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
1,368,339
+1577%
1,460,932
$2.80
$4,086,234.50
BUY
28 Apr 2023
ORBIMED ADVISORS LLC
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
794,368
+230%
1,405,168
$2.61
$3,673,900.80
BUY
28 Apr 2023
GORDON CARL L
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
794,368
+230%
1,405,168
$2.61
$3,673,900.80
BUY
11 Mar 2022
Williams Richard Thomas
Chief Medical Officer, Officer
Kinnate Biopharma Inc.
(KNTE)
42,333
+1714%
40,000
$8.47
$338,850.00
BUY
11 Feb 2022
ORBIMED ADVISORS LLC
Director
Kinnate Biopharma Inc.
(KNTE)
3,509,030
+5%
195,700
$10.17
$1,989,446.00
BUY
11 Feb 2022
GORDON CARL L
Director
Kinnate Biopharma Inc.
(KNTE)
3,509,030
+5%
195,700
$10.17
$1,989,446.00
BUY
3 Dec 2020
Tananbaum James B.
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
500,000
+200%
1,000,000
$20.00
$20,000,000.00
BUY
2 Dec 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
300,000
+166%
750,000
$20.00
$15,000,000.00
BUY
2 Dec 2020
GORDON CARL L
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
300,000
+166%
750,000
$20.00
$15,000,000.00
Home